Management of neonatal sepsis by Gram-negative pathogens

被引:10
|
作者
Venkatesh, Mohan P. [1 ,2 ]
Garcia-Prats, Joseph A. [1 ,2 ]
机构
[1] Texas Childrens Hosp, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
drug resistance; Gram-negative; infection; neonate; outcome; prevention; therapy;
D O I
10.1586/14787210.6.6.929
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
For the pediatrician and neonatologist who care for term and preterm infants, the challenge remains to keep these infants free of infection after delivery in special-care nurseries and neonatal intensive care units. Studies of complications associated with term infants at risk due to maternal factors, as well as preterm infants after early delivery, have demonstrated that sepsis is a major cause of neonatal mortality and morbidity. infections due to Gram-negative organisms are increasingly being reported from neonatal units. Moreover, Gram-negative organisms that are multidrug resistant are on the increase and pose a formidable clinical challenge. in this article, we review current epidemiology, risk factors, clinical features, diagnosis, therapy and preventive measures related to Gram-negative infections in neonates.
引用
收藏
页码:929 / 938
页数:10
相关论文
共 50 条
  • [21] Mucosal surveillance cultures in predicting Gram-negative late-onset sepsis in neonatal intensive care units
    Parm, Ue.
    Metsvaht, T.
    Sepp, E.
    Ilmoja, M. -L.
    Pisarev, H.
    Pauskar, M.
    Lutsar, I.
    JOURNAL OF HOSPITAL INFECTION, 2011, 78 (04) : 327 - 332
  • [22] Multidrug-resistant Gram-negative bacilli sepsis from a neonatal intensive care unit: a case-case-control study
    Thatrimontrichai, Anucha
    Premprat, Nutchana
    Janjindamai, Waricha
    Dissaneevate, Supaporn
    Maneenil, Gunlawadee
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (07): : 603 - 611
  • [23] Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
    Baker, Kristin R.
    Jana, Bimal
    Hansen, Anna Mette
    Nielsen, Hanne Morck
    Franzyk, Henrik
    Guardabassi, Luca
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [24] Drug discovery strategies to outer membrane targets in Gram-negative pathogens
    Brown, Dean G.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (24) : 6320 - 6331
  • [25] Aurodox inhibits type III secretion in multiple Gram-negative pathogens
    Mark, David R.
    O'Boyle, Nicky
    Wale, Kabo R.
    Tucker, Samantha K.
    Mchugh, Rebecca E.
    Roe, Andrew J.
    OPEN BIOLOGY, 2024, 14 (11) : 240240
  • [26] Current opinion in management of septic shock due to Gram-negative bacteria
    Tabah, Alexis
    Buetti, Niccolo
    Barbier, Francois
    Timsit, Jean-Francois
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (06) : 718 - 727
  • [27] Gram-negative sepsis in the intensive care unit: avoiding therapeutic failure
    Chapman, Scott J. R.
    Iredell, Jonathan R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) : 604 - 609
  • [28] Low-dose polymyxin: an option for therapy of Gram-negative sepsis
    Harm, Stephan
    Gabor, Franz
    Hartmann, Jens
    INNATE IMMUNITY, 2016, 22 (04) : 274 - 283
  • [29] Gram-negative groin sepsis treated with covered stents and systemic antibiotics
    Leon, Luis R., Jr.
    Thai, Janice
    Pacanowski, John P.
    VASCULAR, 2011, 19 (04) : 226 - 231
  • [30] Reversal of the Pathophysiological Responses to Gram-Negative Sepsis by Megadose Vitamin C
    Lankadeva, Yugeesh R.
    Peiris, Rachel M.
    Okazaki, Nobuki
    Birchall, Ian E.
    Trask-Marino, Anton
    Dornom, Anthony
    Vale, Tom A. M.
    Evans, Roger G.
    Yanase, Fumitaka
    Bellomo, Rinaldo
    May, Clive N.
    CRITICAL CARE MEDICINE, 2021, 49 (02) : E179 - E190